Issue 12/2019
Content (20 Articles)
Bisphosphonates and lower mortality risk: when it sounds to be good to be true …
W. D. Leslie
Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials
S. Lou, X. Shi, X. Zhang, H. Lyu, Z. Li, Y. Wang
Fracture-induced changes in biomarkers CTX, PINP, OC, and BAP—a systematic review
F.D. Højsager, M.S. Rand, S.B. Pedersen, N. Nissen, N.R. Jørgensen
Bone health in estrogen-free contraception
P. Hadji, E. Colli, P.-A. Regidor
Lessons learned with Bone Health TeleECHO: making treatment decisions when guidelines conflict
M. S. Rothman, T. P. Olenginski, I. Stanciu, K. Krohn, E. M. Lewiecki
The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis
C. Tebé, D. Martínez-Laguna, C. Carbonell-Abella, C. Reyes, V. Moreno, A. Diez-Perez, G.S. Collins, D. Prieto-Alhambra
Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy—a long-term radiological follow-up
M.A. Png, P.C. Mohan, J.S.B. Koh, C.Y. Howe, T.S. Howe
Bone material strength in normoglycemic and hyperglycemic black and white older adults
B. Dawson-Hughes, M. Bouxsein, K. Shea
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
D.L. Kendler, H.G. Bone, F. Massari, E. Gielen, S. Palacios, J. Maddox, C. Yan, S. Yue, R.V. Dinavahi, C. Libanati, A. Grauer
A bone resorption marker as predictor of rate of change in femoral neck size and strength during the menopause transition
A. Shieh, S. Ishii, G.A. Greendale, J.A. Cauley, C. Karvonen-Gutierrez, A.S. Karlamangla
The association between sarcopenia and osteoporotic vertebral compression refractures
W.-F. Wang, C.-W. Lin, C.-N Xie, H.-T Liu, M.-Y. Zhu, K.-L. Huang, H.-L. Teng
A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females
X. Zhang, H. Pang, Y. Dong, D. Shi, F. Liu, Y. Luo, T. Yu, X. Wang
Comorbidity as the dominant predictor of mortality after hip fracture surgeries
Eric Wei Liang Cher, John Carson Allen, Tet Sen Howe, Joyce Suang Bee Koh
Rapid suppression of bone formation marker in response to sleep restriction and circadian disruption in men
C.M. Swanson, W.M. Kohrt, P. Wolfe, K.P. Wright Jr., S.A. Shea, S.W. Cain, M. Munch, N. Vujović, C.A. Czeisler, E.S. Orwoll, O.M. Buxton
Rate of drop in serum calcium as a predictor of hypocalcemic symptoms post total thyroidectomy
R.K. Saad, N.G. Boueiz, V.C. Akiki, G.A.E.-H. Fuleihan
Elderly males with or without existing osteoporotic vertebral fracture have much lower future vertebral fracture risk than elderly females: the MrOS (Hong Kong) year-4 follow-up spine radiograph study
Y.X.J. Wáng, N. Che-Nordin, M. Deng, J.F. Griffith, J.C.S. Leung, A.W.L. Kwok, P.C. Leung, T.C.Y. Kwok
Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure
J.C. Lo, C.D. Grimsrud, S.M. Ott, M. Chandra, R.L. Hui, B. Ettinger
Calcifediol or vitamin D to optimize vitamin D status: Reply to letter of M Sosas
R. Bouillon, J. M. Quesada-Gomez
Drug holidays in osteoporosis treatment: mind the gaps!
P. Anagnostis, I. Lambrinoudaki, E. Kenanidis, M. Potoupnis, E. Tsiridis, D.G. Goulis